Original ResearchPublished 29 September 2026NMA plus antitumor therapy versus antitumor therapy alone in patients with BCLC stage B or C hepatocellular carcinoma and pre-cachexia or cachexia: protocol for a prospective, multicenter, randomized, open-label phase II trialRuihong Dai · Facheng Lu · Weibing Leng · Qing He · Wenhao Guo · Tao Hai · Chang LiuFrontiers in Gastroenterologydoi 10.3389/fgstr.2026.1926294
Original ResearchPublished 9 September 2026Real-world reduction in nightmare frequency and distress among San Francisco first responders treated with a prescription wearable device: a 60-day open-label pilotBrian D. Robertson · Emily F. Wargo · Joel FayFrontiers in Sleepdoi 10.3389/frsle.2026.1941077
Original ResearchPublished 19 June 2026Efficacy assessment in trials of complex and rare diseases: a comparison between the meta-analytic global statistical test and co-primary analysisSamuel P. Dickson · Abe Durrant · Caleb W. Dayley · Joshua R. Christensen · Craig H. Mallinckrodt · Suzanne B. HendrixFrontiers in Medical Technologydoi 10.3389/fmedt.2026.1819463
